Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001385268 | SCV001585048 | pathogenic | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7; Autosomal recessive limb-girdle muscular dystrophy type 2U | 2020-09-24 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exons 9-10 of the ISPD gene. The 5' boundary is likely confined to intron 8. The 3' end of this event is unknown as it extends through the termination codon beyond the assayed region for this gene and may encompass additional genes. While this deletion is not anticipated to result in nonsense mediated decay, it is expected to create a truncated protein product or disrupt mRNA translation. Similar deletions of exons 9-10 have been observed to be homozygous or in combination with another ISPD variant in individuals affected with Walker-Warburg syndrome (PMID:22522421, 22522420, 24120487). For these reasons, this variant has been classified as Pathogenic. |